Joy Britten

772 total citations
40 papers, 629 citations indexed

About

Joy Britten is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Joy Britten has authored 40 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Obstetrics and Gynecology, 25 papers in Reproductive Medicine and 4 papers in Surgery. Recurrent topics in Joy Britten's work include Uterine Myomas and Treatments (33 papers), Endometriosis Research and Treatment (25 papers) and Gynecological conditions and treatments (7 papers). Joy Britten is often cited by papers focused on Uterine Myomas and Treatments (33 papers), Endometriosis Research and Treatment (25 papers) and Gynecological conditions and treatments (7 papers). Joy Britten collaborates with scholars based in United States, Australia and United Kingdom. Joy Britten's co-authors include Minnie Malik, William H. Catherino, Terrence D. Lewis, James H. Segars, J.M. Norian, Gary Levy, Marie‐Victoire Sénat, P. Schwärzler, Y. Ville and J. P. Bernard and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Radiation Oncology*Biology*Physics and Fertility and Sterility.

In The Last Decade

Joy Britten

40 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joy Britten United States 15 477 435 55 53 53 40 629
Nam D. Tran United States 14 412 0.9× 528 1.2× 212 3.9× 60 1.1× 137 2.6× 27 902
Jane Ruman United States 12 90 0.2× 547 1.3× 144 2.6× 48 0.9× 105 2.0× 19 823
Gregg Van de Putte Norway 14 115 0.2× 219 0.5× 60 1.1× 66 1.2× 188 3.5× 25 597
Xin Zhen China 15 164 0.3× 252 0.6× 23 0.4× 51 1.0× 168 3.2× 32 551
Charles W. Yowell United States 8 138 0.3× 222 0.5× 16 0.3× 33 0.6× 89 1.7× 9 497
Haruko Fujii Japan 11 113 0.2× 137 0.3× 6 0.1× 35 0.7× 89 1.7× 19 368
Refika Yigit Netherlands 10 108 0.2× 159 0.4× 17 0.3× 28 0.5× 54 1.0× 18 712
Branko Cvjetičanin Slovenia 8 86 0.2× 187 0.4× 17 0.3× 81 1.5× 372 7.0× 18 580
J Drury United Kingdom 6 170 0.4× 193 0.4× 36 0.7× 13 0.2× 41 0.8× 12 341

Countries citing papers authored by Joy Britten

Since Specialization
Citations

This map shows the geographic impact of Joy Britten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Britten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Britten more than expected).

Fields of papers citing papers by Joy Britten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Britten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Britten. The network helps show where Joy Britten may publish in the future.

Co-authorship network of co-authors of Joy Britten

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Britten. A scholar is included among the top collaborators of Joy Britten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Britten. Joy Britten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Malik, Minnie, et al.. (2022). Curcumin inhibits human leiomyoma xenograft tumor growth and induces dissolution of the extracellular matrix. PubMed. 4(1). 74–89. 7 indexed citations
4.
Britten, Joy, et al.. (2020). Three-dimensional human leiomyoma xenografts induce angiogenesis by inducing hypoxia inducible factor-1 alpha. PubMed. 2(2). 219–227. 3 indexed citations
5.
DeAngelis, Anthony M., et al.. (2020). Characterization of the role of Activator Protein 1 signaling pathway on extracellular matrix deposition in uterine leiomyoma. PubMed. 1(1). 78–89. 6 indexed citations
6.
Malik, Minnie, Joy Britten, & William H. Catherino. (2020). Development and Validation of Hormonal Impact of a Mouse Xenograft Model for Human Uterine Leiomyoma. Reproductive Sciences. 27(6). 1304–1317. 11 indexed citations
7.
8.
Malik, Minnie, Joy Britten, & William H. Catherino. (2019). IL6 and STAT-3 pathway highlight the differences in molecular responses in myometrium and uterine fibroids. Fertility and Sterility. 112(3). e350–e350. 3 indexed citations
9.
Lewis, Terrence D., et al.. (2019). Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms. Fertility and Sterility. 111(4). 806–815.e1. 29 indexed citations
10.
Malik, Minnie, Joy Britten, Mostafa A. Borahay, James H. Segars, & William H. Catherino. (2018). Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production. Fertility and Sterility. 110(7). 1398–1407.e1. 38 indexed citations
11.
Britten, Joy, Minnie Malik, Terrence D. Lewis, & William H. Catherino. (2018). Ulipristal Acetate Mediates Decreased Proteoglycan Expression Through Regulation of Nuclear Factor of Activated T-Cells (NFAT5). Reproductive Sciences. 26(2). 184–197. 14 indexed citations
12.
13.
Malik, Minnie, et al.. (2015). Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones. Fertility and Sterility. 105(1). 214–224. 28 indexed citations
14.
Malik, Minnie, Joy Britten, James H. Segars, & William H. Catherino. (2014). Leiomyoma Cells in 3-Dimensional Cultures Demonstrate an Attenuated Response to Fasudil, a Rho-Kinase Inhibitor, When Compared to 2-Dimensional Cultures. Reproductive Sciences. 21(9). 1126–1138. 28 indexed citations
15.
Levy, Gary, et al.. (2014). Liarozole inhibits transforming growth factor-β3–mediated extracellular matrix formation in human three-dimensional leiomyoma cultures. Fertility and Sterility. 102(1). 272–281.e2. 22 indexed citations
17.
Malik, Minnie, et al.. (2012). Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent. Fertility and Sterility. 98(6). 1557–1562. 19 indexed citations
18.
Malik, Minnie, et al.. (2011). Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells. Fertility and Sterility. 95(7). 2383–2387. 28 indexed citations
19.
Malik, Minnie, et al.. (2010). Why Leiomyomas Are Called Fibroids: The Central Role of Extracellular Matrix in Symptomatic Women. Seminars in Reproductive Medicine. 28(3). 169–179. 115 indexed citations
20.
Sénat, Marie‐Victoire, J. P. Bernard, P. Schwärzler, Joy Britten, & Y. Ville. (1999). Prenatal diagnosis and follow‐up of 14 cases of unilateral ventriculomegaly. Ultrasound in Obstetrics and Gynecology. 14(5). 327–332. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026